We are excited to highlight Dr. Aman Chauhan as a distinguished figure in the field of oncology.
Dr. Aman Chauhan is a prominent presence on X/Twitter and LinkedIn, where he shares his expertise in treating neuroendocrine tumors (NETs). He leads the Neuroendocrine Cancer Program at Sylvester Comprehensive Cancer Center, focusing on various NETs, including carcinoid tumors and high-grade neuroendocrine carcinomas.
In addition to his clinical work, Dr. Chauhan is the national principal investigator for several investigator-initiated neuroendocrine cancer theranostics clinical trials. His involvement in these trials reflects his commitment to advancing treatment options for neuroendocrine cancers.
Dr. Chauhan also serves on the AJCC and ASCO NET guideline committees and is an active member of the NANETS communication committee, contributing to the development of guidelines and communication strategies in the field.
Follow Dr. Aman Chauhan on X/Twitter and LinkedIn to stay informed about his groundbreaking work in neuroendocrine tumors and his contributions to advancing research and clinical practice in oncology.
About Dr. Aman Chauhan
Dr. Aman Chauhan is a leading oncologist renowned for his focus on neuroendocrine tumors (NETs). As the leader of the Neuroendocrine Cancer Program at Sylvester Comprehensive Cancer Center, he specializes in treating various NETs, including carcinoid tumors and high-grade neuroendocrine carcinomas.
His role as the national principal investigator for several investigator-initiated neuroendocrine cancer theranostics clinical trials underscores his dedication to improving treatment options for these challenging cancers. Dr. Chauhan’s expertise is further demonstrated through his participation in the AJCC and ASCO NET guideline committees and his active involvement in the NANETS communication committee.
Dr. Chauhan’s extensive experience and leadership continue to drive progress in the treatment and research of neuroendocrine tumors.
Stay tuned for more OncoInfluencers and check out previous profiles on our website to discover other influential voices in the oncology community.